Journey Medical (DERM) Operating Income (2020 - 2025)
Historic Operating Income for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to -$1.5 million.
- Journey Medical's Operating Income rose 4716.66% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 6949.76%. This contributed to the annual value of -$13.7 million for FY2024, which is 55976.85% down from last year.
- According to the latest figures from Q3 2025, Journey Medical's Operating Income is -$1.5 million, which was up 4716.66% from -$2.9 million recorded in Q2 2025.
- Over the past 5 years, Journey Medical's Operating Income peaked at $17.2 million during Q3 2023, and registered a low of -$13.8 million during Q2 2021.
- Over the past 5 years, Journey Medical's median Operating Income value was -$3.3 million (recorded in 2025), while the average stood at -$4.5 million.
- Per our database at Business Quant, Journey Medical's Operating Income crashed by 539121.34% in 2021 and then skyrocketed by 28167.93% in 2023.
- Quarter analysis of 5 years shows Journey Medical's Operating Income stood at -$9.1 million in 2021, then dropped by 10.36% to -$10.0 million in 2022, then surged by 78.95% to -$2.1 million in 2023, then soared by 206.18% to $2.2 million in 2024, then crashed by 168.44% to -$1.5 million in 2025.
- Its Operating Income was -$1.5 million in Q3 2025, compared to -$2.9 million in Q2 2025 and -$3.3 million in Q1 2025.